The effect of ACE-I/ARBs and beta blockers on the development of cardiotoxicity in patients with breast cancer

Back

ESC Professional Premium Access

The effect of ACE-I/ARBs and beta blockers on the development of cardiotoxicity in patients with breast cancer

Session: Cardio-oncology 1

Topic: Cardio-Oncology

Speaker: Doctor G. Umadat (Jacksonville, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Goyal Umadat

Mayo Clinic, Jacksonville (United States of America)

0 follower

5 more presentations in this session

Prevalence of RV dysfunction in patients under cardiotoxic chemoterapy: a preliminary analysis

Speaker: Doctor S. Maltes (Lisbon, PT)

Access

Abstract

Slides

Valvular changes following anthracycline therapy: is it time to look beyond ejection fraction?

Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)

Access

Abstract

Slides

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry

Speaker: Doctor P. Guedeney (Paris, FR)

Access

Abstract

Slides

Emergency department cardiovascular disease encounters and associated mortality in patients with cancer: a study of 20.6 million records from the USA

Speaker: Doctor O. Kobo (Hadera, IL)

Access

Abstract

Slides

Cardio-Oncology: a medical specialty in constant growth and evolution. the 10-year experience of the first cardio-oncology service in the United Kingdom

Speaker: Doctor M. Andres (Harefield, Uxbridge, GB)

Access

Abstract

Slides

Access the full session

Cardio-oncology 1

Speakers: Doctor G. Umadat, Doctor S. Maltes, Doctor M. Laufer-Perl, Doctor P. Guedeney, Doctor O. Kobo...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources